Key Insights

Highlights

Success Rate

92% trial completion (above average)

Research Maturity

59 completed trials (47% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.0%

5 terminated out of 126 trials

Success Rate

92.2%

+5.6% vs benchmark

Late-Stage Pipeline

21%

26 trials in Phase 3/4

Results Transparency

8%

5 of 59 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

120Total
Not Applicable (67)
Early P 1 (4)
P 1 (9)
P 2 (14)
P 3 (6)
P 4 (20)

Trial Status

Completed59
Unknown28
Not Yet Recruiting15
Recruiting9
Active Not Recruiting5
Terminated5

Trial Success Rate

92.2%

Benchmark: 86.5%

Based on 59 completed trials

Clinical Trials (126)

Showing 20 of 20 trials
NCT07732192Phase 4Not Yet RecruitingPrimary

Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in Melasma

NCT07727954Not ApplicableCompletedPrimary

Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma

NCT07679945Not ApplicableRecruiting

A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants

NCT07676994Phase 4CompletedPrimary

Efficacy of New Trio Combination for Melasma

NCT07667972Not ApplicableActive Not RecruitingPrimary

Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea

NCT07644871Not ApplicableCompleted

A 4-week Study Investigating Two Targeted Brightening Serum (A and B) Versus 4% Hydroquinone in Women With Mild to Severe Full-face Hyperpigmentation

NCT07604844Not ApplicableNot Yet RecruitingPrimary

Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel in the Treatment of Melasma

NCT07036302Not ApplicableActive Not RecruitingPrimary

Comparative Effects Of Trichloroacetic Chemical Peel And Fractional Laser

NCT07540702Not ApplicableRecruitingPrimary

Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma

NCT07530016Not ApplicableNot Yet RecruitingPrimary

Clinical Efficacy and Mechanisms of a Topical Azone-Tranexamic Acid-Aloe Polysaccharide Gel in the Treatment of Melasma

NCT07522788Phase 4Not Yet RecruitingPrimary

Comparison Between Efficacy of Topical Tranexamic Acid Vs Topical Ethyl Ascorbic Acid In Treatment Of Melasma

NCT07495748Not ApplicableNot Yet RecruitingPrimary

Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma

NCT03877445Not ApplicableCompletedPrimary

Study of the Influence of Blue Light Emitted by Computer / Television Screens on Melasma MELABLUE Study

NCT07485777Not ApplicableNot Yet Recruiting

Comparative Evaluation of Topical 30% Metformin and Kligman's Regimen in Women With Melasma

NCT07448415Phase 2Not Yet RecruitingPrimary

Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma

NCT07429786Not ApplicableNot Yet Recruiting

Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions

NCT06616311Not ApplicableCompletedPrimary

Efficacy of Radiofrequency Micro Needling for the Treatment of Melasma in Skin of Color.

NCT06677931Not ApplicableCompletedPrimary

Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma

NCT07345507Not ApplicableCompletedPrimary

Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi

NCT07327983Not ApplicableCompletedPrimary

Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma

Scroll to load more

Research Network

Activity Timeline